Financials
Financial year 2025
HECK PHARMA from Büllingen, company number BE0779610477, closed financial year 2025 with a result of € 176,188 after tax. For that financial year HECK PHARMA recorded a gross margin of € 451,911 and equity of € 168,197. Compared with financial year 2024, the result moved from € 123,117 to € 176,188. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.
€ 168,197
▲ 27% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 176,188
▲ 43% vs 2024
Profit after tax over the fiscal year.
€ 318,656
▲ 39% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 140,000 paid out
79 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 200,955
▲ 5% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 4,982
▼ 49% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 155,122
▼ 9% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 59,793
▲ 55% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 350,946 | € 404,557 | € 370,354 | € 451,911 | ▲ 22% |
| Profit after taxes | € 127,907 | € 160,985 | € 123,117 | € 176,188 | ▲ 43% |
| Equity | € 47,907 | € 108,892 | € 132,009 | € 168,197 | ▲ 27% |
| Total debts | € 270,636 | € 291,980 | € 309,109 | € 353,972 | ▲ 15% |
| Cash | € 141,932 | € 210,456 | € 229,599 | € 318,656 | ▲ 39% |
| Land & buildings | - | - | € 5,446 | € 5,165 | ▼ 5% |
| Retained profit | € 27,907 | € 88,892 | € 112,009 | € 148,197 | ▲ 32% |
| Dividend | € 100,000 | € 100,000 | € 100,000 | € 140,000 | ▲ 40% |
| Balance sheet total | € 318,542 | € 400,872 | € 441,119 | € 522,168 | ▲ 18% |
Key figures of HECK PHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to HECK PHARMA?
What happened at HECK PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 176,188 (▲ 43% vs 2024). Source: NBB ↗
- New establishment in Büllingen. KBO
- Start of the company according to the CBE. KBO
In short
From € 127,907 profit in 2022 to € 176,188 profit in 2025.
Paid € 207,782 in corporate taxes since 2022.
Best year ever: 2025, with € 176,188 profit.
Paid out € 440,000 in dividends to the owners in total.
Management
Behind HECK PHARMA are Arthur HECK, Stephanie Katharina HECK, Roman Ambross HECK, Daniella Maria GRAVEN and Alexander Donat HECK.
Directors
According to the 2025 annual accounts
Arthur HECK
Director
Stephanie Katharina HECK
Director
Roman Ambross HECK
Director
Daniella Maria GRAVEN
Director
Alexander Donat HECK
Director
Establishments
Establishment units
Physical locations of this company
Hauptstrasse 24
4760 Büllingen
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0779.610.477
- VAT number
- BE 0779.610.477
- Registered office
- Hauptstrasse 24, 4760 Büllingen
- Names & denominations
- HECK PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 3 January 2022
- Peppol
- Active · Active since 2 Sept 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Verhuur en lease van medisch en paramedisch materieel